The treatment of malignant pleural effusions.
D000230:Adenocarcinoma / Q000150:complications; D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000150:complications; D018288:Carcinoma, Small Cell / Q000150:complications; D002294:Carcinoma, Squamous Cell / Q000150:complications; D004322:Drainage; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications; D008175:Lung Neoplasms / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008545:Melanoma / Q000150:complications; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D010051:Ovarian Neoplasms / Q000150:complications; D010994:Pleura / Q000601:surgery; D010996:Pleural Effusion / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012878:Skin Neoplasms / Q000150:complications; D014594:Uterine Neoplasms / Q000150:complications
D008466:Mechlorethamine